Published in J Pediatr on September 01, 1985
Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev (1996) 13.91
Microbiology of airway disease in patients with cystic fibrosis. Clin Microbiol Rev (1991) 7.12
The changing microbial epidemiology in cystic fibrosis. Clin Microbiol Rev (2010) 4.22
Evaluation of matrix-assisted laser desorption ionization-time-of-flight mass spectrometry in comparison to 16S rRNA gene sequencing for species identification of nonfermenting bacteria. J Clin Microbiol (2008) 4.18
Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis: analysis by randomly amplified polymorphic DNA fingerprinting. J Clin Microbiol (1996) 2.95
Linkage analysis of geographic and clinical clusters in Pseudomonas cepacia infections by multilocus enzyme electrophoresis and ribotyping. J Clin Microbiol (1994) 2.74
Identification and characterization of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis. J Clin Microbiol (1997) 2.72
Selective and differential medium for recovery of Pseudomonas cepacia from the respiratory tracts of patients with cystic fibrosis. J Clin Microbiol (1987) 2.59
Infection control in cystic fibrosis. Clin Microbiol Rev (2004) 2.45
Agricultural use of Burkholderia (Pseudomonas) cepacia: a threat to human health? Emerg Infect Dis (1998) 2.43
Laboratory proficiency test results on use of selective media for isolating Pseudomonas cepacia from simulated sputum specimens of patients with cystic fibrosis. J Clin Microbiol (1987) 2.31
Use of ribotyping in epidemiological surveillance of nosocomial outbreaks. Clin Microbiol Rev (1994) 2.26
Clinical significance of microbial infection and adaptation in cystic fibrosis. Clin Microbiol Rev (2011) 2.23
Subgrouping of Pseudomonas cepacia by cellular fatty acid composition. J Clin Microbiol (1989) 2.23
Cable (cbl) type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers. J Bacteriol (1995) 2.16
Epidemic of Pseudomonas cepacia in an adult cystic fibrosis unit: evidence of person-to-person transmission. J Clin Microbiol (1993) 2.12
Specific and rapid detection by fluorescent in situ hybridization of bacteria in clinical samples obtained from cystic fibrosis patients. J Clin Microbiol (2000) 1.91
Binding of Pseudomonas cepacia to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis. J Clin Invest (1992) 1.80
Outcome of Burkholderia (Pseudomonas) cepacia colonisation in children with cystic fibrosis following a hospital outbreak. Thorax (1995) 1.78
Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis. Thorax (2004) 1.71
Arbitrarily primed polymerase chain reaction as a rapid method to differentiate crossed from independent Pseudomonas cepacia infections in cystic fibrosis patients. J Clin Microbiol (1993) 1.60
An epidemic of burkholderia cepacia transmitted between patients with and without cystic fibrosis. J Infect Dis (1999) 1.59
Pseudomonas cepacia: a new pathogen in patients with cystic fibrosis referred to a large centre in the United Kingdom. Arch Dis Child (1990) 1.55
Comparison of culture and PCR for detection of Burkholderia cepacia in sputum samples of patients with cystic fibrosis. J Clin Microbiol (1998) 1.50
Role of flagella in host cell invasion by Burkholderia cepacia. Infect Immun (2002) 1.46
Marked phenotypic variability in Pseudomonas cepacia isolated from a patient with cystic fibrosis. J Clin Microbiol (1993) 1.45
Comparative evaluation of selective media for isolation of Pseudomonas cepacia from cystic fibrosis patients and environmental sources. J Clin Microbiol (1988) 1.37
Identification of the mucin-binding adhesin of Pseudomonas cepacia isolated from patients with cystic fibrosis. Infect Immun (1992) 1.35
Controlled study of Pseudomonas cepacia and Pseudomonas maltophilia in cystic fibrosis. Arch Dis Child (1992) 1.31
Pseudomonas cepacia adherence to respiratory epithelial cells is enhanced by Pseudomonas aeruginosa. Infect Immun (1990) 1.27
Production of lipase by clinical isolates of Pseudomonas cepacia. J Clin Microbiol (1988) 1.25
Laboratory aspects of management of chronic pulmonary infections in patients with cystic fibrosis. J Clin Microbiol (2003) 1.23
Reconstitution of O-specific lipopolysaccharide expression in Burkholderia cenocepacia strain J2315, which is associated with transmissible infections in patients with cystic fibrosis. J Bacteriol (2005) 1.20
Outer membrane permeability in Pseudomonas cepacia: diminished porin content in a beta-lactam-resistant mutant and in resistant cystic fibrosis isolates. Antimicrob Agents Chemother (1988) 1.20
Enhanced susceptibility to pulmonary infection with Burkholderia cepacia in Cftr(-/-) mice. Infect Immun (2001) 1.19
Burkholderia cepacia respiratory tract acquisition: epidemiology and molecular characterization of a large nosocomial outbreak. Epidemiol Infect (1996) 1.18
Identification of IS1356, a new insertion sequence, and its association with IS402 in epidemic strains of Burkholderia cepacia infecting cystic fibrosis patients. J Clin Microbiol (1996) 1.16
In vitro activities of meropenem, PD 127391, PD 131628, ceftazidime, chloramphenicol, co-trimoxazole, and ciprofloxacin against Pseudomonas cepacia. Antimicrob Agents Chemother (1993) 1.15
Burkholderia cenocepacia C5424 produces a pigment with antioxidant properties using a homogentisate intermediate. J Bacteriol (2007) 1.13
Lung infections. 3. Pseudomonas aeruginosa and other related species. Thorax (1998) 1.08
Capillary electrophoresis-single-strand conformation polymorphism analysis for rapid identification of Pseudomonas aeruginosa and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis. J Clin Microbiol (1999) 1.08
Outcome of Burkholderia cepacia colonisation in an adult cystic fibrosis centre. Thorax (2002) 1.08
Role of bacteriocins in mediating interactions of bacterial isolates taken from cystic fibrosis patients. Microbiology (2010) 1.07
Six-year molecular analysis of Burkholderia cepacia complex isolates among cystic fibrosis patients at a referral center for lung transplantation. J Clin Microbiol (2002) 1.06
Pseudomonas cepacia in cystic fibrosis. Thorax (1994) 1.00
Pulmonary evolution of cystic fibrosis patients colonized by Pseudomonas aeruginosa and/or Burkholderia cepacia. Eur J Pediatr (1998) 0.99
Burkholderia (basonym Pseudomonas) cepacia binding to lipid receptors. Infect Immun (1996) 0.97
Neutralizing monoclonal antibodies to an extracellular Pseudomonas cepacia protease. Infect Immun (1994) 0.97
Burkholderia cepacia is associated with pulmonary hypertension and increased mortality among cystic fibrosis patients. J Clin Microbiol (2004) 0.95
Can early Burkholderia cepacia complex infection in cystic fibrosis be eradicated with antibiotic therapy? Front Cell Infect Microbiol (2011) 0.92
Use of the E test to assess synergy of antibiotic combinations against isolates of Burkholderia cepacia-complex from patients with cystic fibrosis. Eur J Clin Microbiol Infect Dis (2003) 0.91
Comparative in vitro activities of meropenem, imipenem, temocillin, piperacillin, and ceftazidime in combination with tobramycin, rifampin, or ciprofloxacin against Burkholderia cepacia isolates from patients with cystic fibrosis. Antimicrob Agents Chemother (1999) 0.90
In vitro efficacy of high-dose tobramycin against Burkholderia cepacia complex and Stenotrophomonas maltophilia isolates from cystic fibrosis patients. Antimicrob Agents Chemother (2014) 0.86
Epidemiology of Pseudomonas cepacia in cystic fibrosis. Can J Infect Dis (1993) 0.86
Intercontinental spread of a highly transmissible clone of Pseudomonas cepacia proved by multilocus enzyme electrophoresis and ribotyping. Can J Infect Dis (1994) 0.84
Does carbon dioxide retention during exercise predict a more rapid decline in FEV1 in cystic fibrosis? Arch Dis Child (2005) 0.84
Should patients with cystic fibrosis infected with Burkholderia cepacia undergo lung transplantation? Thorax (1997) 0.82
Organisms isolated from adults with cystic fibrosis. Ann Clin Microbiol Antimicrob (2004) 0.81
Identification of potential diagnostic markers among Burkholderia cenocepacia and B. multivorans supernatants. J Clin Microbiol (2010) 0.80
Cystic fibrosis. Thorax (2001) 0.80
Effects of lung transplantation on inpatient end of life care in cystic fibrosis. J Cyst Fibros (2007) 0.79
Activity of Tobramycin against Cystic Fibrosis Isolates of Burkholderia cepacia Complex Grown as Biofilms. Antimicrob Agents Chemother (2015) 0.78
Screening a mushroom extract library for activity against Acinetobacter baumannii and Burkholderia cepacia and the identification of a compound with anti-Burkholderia activity. Ann Clin Microbiol Antimicrob (2010) 0.77
Randomized double-blind evaluation of ceftazidime dose ranging in hospitalized patients with cystic fibrosis. Antimicrob Agents Chemother (1987) 0.77
A case of native valve endocarditis caused by Burkholderia cepacia without predisposing factors. BMC Infect Dis (2011) 0.75
Clinafloxacin for Treatment of Burkholderia cenocepacia Infection in a Cystic Fibrosis Patient. Antimicrob Agents Chemother (2015) 0.75
Intramural bladder-wall abscess: a late complication arising after a urethrocystoscopy? Pediatr Surg Int (2005) 0.75
Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System. Am J Med (1991) 9.11
The epidemiology of AIDS: current status and future prospects. Science (1985) 8.73
CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol (1992) 8.28
Emergence of vancomycin resistance in coagulase-negative staphylococci. N Engl J Med (1987) 7.82
The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol (1985) 6.94
The emergence of methicillin-resistant Staphylococcus aureus infections in United States hospitals. Possible role of the house staff-patient transfer circuit. Ann Intern Med (1982) 6.62
Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991. Infect Control Hosp Epidemiol (1992) 5.98
Recovery of resistant enterococci during vancomycin prophylaxis. J Clin Microbiol (1988) 5.71
Epidemiology of HIV infection and AIDS in the United States. Science (1988) 5.53
Strategies to Prevent and Control the Emergence and Spread of Antimicrobial-Resistant Microorganisms in Hospitals. A challenge to hospital leadership. JAMA (1996) 4.80
Surgical wound infection rates by wound class, operative procedure, and patient risk index. National Nosocomial Infections Surveillance System. Am J Med (1991) 4.72
Review of death certificates to assess completeness of AIDS case reporting. Public Health Rep (1987) 4.66
THE PREPARATION AND ABSORPTION SPECTRA OF FIVE PURE CAROTENOID PIGMENTS. Plant Physiol (1942) 4.65
The economic impact of the first 10,000 cases of acquired immunodeficiency syndrome in the United States. JAMA (1986) 4.60
Acquired immunodeficiency syndrome: current and future trends. Public Health Rep (1986) 4.22
Multidrug-resistant tuberculosis. Ann Intern Med (1992) 4.06
Pseudomonas aeruginosa: growth in distilled water from hospitals. Science (1971) 3.82
Predominant pathogens in hospital infections. J Antimicrob Chemother (1992) 3.79
The nationwide nosocomial infection rate. A new need for vital statistics. Am J Epidemiol (1985) 3.70
Something is (not) rotten in Denmark [Hamlet (not) W. Shakespeare]. Pediatr Pulmonol (1997) 3.51
Control of vancomycin-resistant enterococcus in health care facilities in a region. N Engl J Med (2001) 3.33
Efficacy of aerosolized tobramycin in patients with cystic fibrosis. N Engl J Med (1993) 3.27
II. The Present Position of the Surgery of the Hypertrophied Prostate. Ann Surg (1893) 3.21
Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis. J Clin Microbiol (1996) 3.20
Isolation medium for the recovery of Pseudomonas cepacia from respiratory secretions of patients with cystic fibrosis. J Clin Microbiol (1985) 3.09
Colonization of skilled-care facility residents with antimicrobial-resistant pathogens. J Am Geriatr Soc (2001) 3.06
Serratia liquefaciens bloodstream infections from contamination of epoetin alfa at a hemodialysis center. N Engl J Med (2001) 3.02
The incidence rate of acquired immunodeficiency syndrome in selected populations. JAMA (1985) 3.00
National nosocomial infections surveillance system (NNIS): description of surveillance methods. Am J Infect Control (1991) 3.00
Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis. Risk factors and outcomes. Chest (1987) 2.97
CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Am J Infect Control (1992) 2.95
Case definitions for public health surveillance. MMWR Recomm Rep (1990) 2.93
Global carbon sinks and their variability inferred from atmospheric O2 and delta13C. Science (2000) 2.83
Timeliness of national reporting of communicable diseases: the experience of the National Electronic Telecommunications System for Surveillance. Am J Public Health (1991) 2.81
A cluster of Rhodococcus (Gordona) Bronchialis sternal-wound infections after coronary-artery bypass surgery. N Engl J Med (1991) 2.73
Growth characteristics of atypical mycobacteria in water and their comparative resistance to disinfectants. Appl Environ Microbiol (1978) 2.64
A Large Northern Hemisphere Terrestrial CO2 Sink Indicated by the 13C/12C Ratio of Atmospheric CO2. Science (1995) 2.62
Ribotype analysis of Pseudomonas cepacia from cystic fibrosis treatment centers. J Pediatr (1988) 2.60
Selective and differential medium for recovery of Pseudomonas cepacia from the respiratory tracts of patients with cystic fibrosis. J Clin Microbiol (1987) 2.59
Women's vulnerability to sexual assault from adolescence to young adulthood. J Adolesc Health (2000) 2.50
Factors affecting comparative resistance of naturally occurring and subcultured Pseudomonas aeruginosa to disinfectants. Appl Microbiol (1972) 2.47
The Choice of the Fixating Eye in Paralytic and Non-Paralytic Strabismus. Trans Am Ophthalmol Soc (1943) 2.45
Mortality and infectious disease associated with infant-feeding practices in developing countries. Pediatrics (1984) 2.42
Infections with Mycobacterium chelonei in patients receiving dialysis and using processed hemodialyzers. J Infect Dis (1985) 2.39
Airborne spread of brucellosis. Ann N Y Acad Sci (1980) 2.33
Clinical experience over 48 years with pheochromocytoma. Ann Surg (1999) 2.32
Transmission of multidrug-resistant serotype 23F Streptococcus pneumoniae in group day care: evidence suggesting capsular transformation of the resistant strain in vivo. J Infect Dis (1995) 2.31
Laboratory proficiency test results on use of selective media for isolating Pseudomonas cepacia from simulated sputum specimens of patients with cystic fibrosis. J Clin Microbiol (1987) 2.31
Gram-negative water bacteria in hemodialysis systems. Health Lab Sci (1975) 2.28
Pseudomonas cepacia typing systems: collaborative study to assess their potential in epidemiologic investigations. Rev Infect Dis (1989) 2.25
Nontuberculous mycobacteria in adult patients with cystic fibrosis. Chest (1992) 2.25
Improved recovery of mycobacteria from respiratory secretions of patients with cystic fibrosis. J Clin Microbiol (1993) 2.22
Guideline for infection control in healthcare personnel, 1998. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol (1998) 2.20
Identifying patients at high risk of surgical wound infection. A simple multivariate index of patient susceptibility and wound contamination. Am J Epidemiol (1985) 2.20
Requirements for infrastructure and essential activities of infection control and epidemiology in hospitals: a consensus panel report. Society for Healthcare Epidemiology of America. Infect Control Hosp Epidemiol (1998) 2.18
Clinical and histologic spectrum of human T-cell lymphotropic virus type I-associated lymphoma involving the skin. J Am Acad Dermatol (1996) 2.14
HIV-1 incidence determined retrospectively among drug users in Bangkok, Thailand. AIDS (1994) 2.11
Invasive group A streptococcal infections in North Carolina: epidemiology, clinical features, and genetic and serotype analysis of causative organisms. J Infect Dis (1997) 2.09
Phonons and the elastic moduli of collagen and muscle. Nature (1977) 2.09
Epidemiologic study of cystic fibrosis: design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the U.S. and Canada. Pediatr Pulmonol (1999) 2.05
Morphological, biochemical, and growth characteristics of pseudomonas cepacia from distilled water. Appl Microbiol (1973) 2.05
Patterns of transmission of epidemic hysteria in a school. Epidemiology (1990) 2.04
Connectivity and resilience of coral reef metapopulations in marine protected areas: matching empirical efforts to predictive needs. Coral Reefs (2009) 1.86
A prolonged outbreak of Pseudomonas aeruginosa in a neonatal intensive care unit: did staff fingernails play a role in disease transmission? Infect Control Hosp Epidemiol (2000) 1.86
Transfusion-transmitted bacterial infection in the United States, 1998 through 2000. Transfusion (2001) 1.81
Prevalence of thymidine-dependent Staphylococcus aureus in patients with cystic fibrosis. J Clin Microbiol (1987) 1.80
The effect of sugar on behavior or cognition in children. A meta-analysis. JAMA (1995) 1.79
Biotype of Haemophilus influenzae: correlation with virulence and ampicillin resistance. J Infect Dis (1983) 1.78
A pilot study of high-dose short duration daptomycin for the treatment of patients with complicated skin and skin structure infections caused by gram-positive bacteria. Int J Clin Pract (2008) 1.76
A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group. J Pediatr (1995) 1.75
Mycobacterium chelonae wound infections after plastic surgery employing contaminated gentian violet skin-marking solution. N Engl J Med (1987) 1.74
Subcutaneous T-cell lymphoma. Report of two additional cases and further observations. Arch Dermatol (1993) 1.73
Importance of culture in laboratory diagnosis of Bordetella pertussis infections. J Clin Microbiol (1984) 1.70
Purpose of quality standards for infectious diseases. Infectious Diseases Society of America. Clin Infect Dis (1994) 1.70
Estimating AIDS infection rates in the San Francisco cohort. AIDS (1988) 1.66
An outbreak of Candida parapsilosis bloodstream infections in patients receiving parenteral nutrition. J Infect Dis (1984) 1.64
From the Center for Disease Control. Trends in human plague in the United States. J Infect Dis (1980) 1.63
Mandatory reporting of occupational diseases by clinicians. JAMA (1989) 1.63
Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis. Am Rev Respir Dis (1993) 1.63
I. The Results of Double Castration in Hypertrophy of the Prostate. Ann Surg (1895) 1.61
Cardiorespiratory changes in children during laparoscopy. J Pediatr Surg (1995) 1.61
Molecular subtyping of Clostridium perfringens by pulsed-field gel electrophoresis to facilitate food-borne-disease outbreak investigations. J Clin Microbiol (1999) 1.60
Primary ciliary dyskinesia: a genome-wide linkage analysis reveals extensive locus heterogeneity. Eur J Hum Genet (2000) 1.57
Quality standard for antimicrobial prophylaxis in surgical procedures. Infectious Diseases Society of America. Clin Infect Dis (1994) 1.56
Relative frequency of Clostridium difficile in patients with diarrheal disease. J Clin Microbiol (1981) 1.56
Effect of altering smooth muscle tone on maximal expiratory flows in patients with tracheomalacia. Pediatr Pulmonol (1990) 1.54
Selection for vancomycin resistance in clinical isolates of Staphylococcus haemolyticus. J Infect Dis (1990) 1.54
Clinical features, survival rate, and prognostic factors in young adults with cystic fibrosis. Am J Med (1987) 1.54
Nosocomial infections among neonates in high-risk nurseries in the United States. National Nosocomial Infections Surveillance System. Pediatrics (1996) 1.53